Tracking Adverse Drug Reactions

Empower your pharmacovigilance efforts with robust safety management

Adverse drug reaction (ADR) tracking is a vital component of any pharmacovigilance program. At QbD Group, we offer advanced solutions designed to simplify and enhance the management of adverse events.

Powered by Vigilazierta, our comprehensive safety database combines expert knowledge with cutting-edge technology to streamline ADR tracking, reporting, and compliance.

What is ADR tracking?

Tracking adverse drug reactions involves the systematic collection, evaluation, and reporting of adverse events associated with medicinal products. This process ensures patient safety, supports regulatory compliance, and provides critical insights for improving drug safety profiles. Key features of ADR tracking:

Centralized data management: Store, organize, and retrieve adverse event data in one secure platform.
Automated workflows: Reduce manual workload with automated case processing, follow-ups, and reporting.
Real-time monitoring: Detect and respond to safety signals as they emerge.
Regulatory compliance: Meet global pharmacovigilance requirements, including EMA, FDA, and WHO guidelines.
Comprehensive documentation: Maintain a detailed record of all activities for audit readiness.

Discover why ADR tracking is essential

Tracking Adverse Drug Reactions - Vigilance - QbD Group

Why is ADR tracking essential?

Effective tracking of adverse drug reactions is critical for ensuring patient safety and maintaining regulatory compliance. Here’s why it matters:

Protects patient safety: Early detection of adverse reactions prevents harm and mitigates risks.
Regulatory compliance: Avoid penalties and maintain market access by adhering to global safety standards.
Supports product development: Insights from ADR tracking enhance drug safety and efficacy profiles.
Builds trust: Demonstrate commitment to safety and quality to patients, regulators, and stakeholders.

Discover how we can support you

State-of-the-art safety database

Vigilazierta enables seamless ADR tracking with user-friendly features and robust data security.

End-to-end support

From case intake to regulatory submission, we streamline every step of the process.

Global compliance

Ensure adherence to international pharmacovigilance regulations.

Expert insights

Benefit from our pharmacovigilance specialists' decades of experience.

Tailored solutions

Customize workflows to meet the unique needs of your organization.

Tracking Adverse Drug Reactions - Vigilance - QbD Group (3)

Why partner with QbD Group?

When you partner with QbD Group, you gain:

Innovative technology: Vigilazierta—developed by pharmacovigilance experts—is more than software; it’s a complete safety management solution.
Trusted expertise: Leverage the knowledge of our experienced team to enhance your ADR tracking.
Scalable solutions: Adaptable tools and processes that grow with your organization.
Comprehensive services: From vigilance in clinical trials to post-market surveillance, we’ve got you covered.

Get in touch

Ready to take control of your adverse drug reaction tracking?

With Vigilazierta and QbD Group’s expertise, you can ensure patient safety, regulatory compliance, and operational efficiency. Reach out to us today to learn how we can help.

Tracking Adverse Drug Reactions

What is ADR tracking?

Why is ADR tracking essential?

How can we help?

State-of-the-art safety database

State-of-the-art safety database

End-to-end support

End-to-end support

Global compliance

Global compliance

Expert insights

Expert insights

Tailored solutions

Tailored solutions

Why partner with QbD Group?

Related content

Establishing and Maintaining the Right Level of Clinical Evidence under the EU IVDR

Post-Market Surveillance (PMS) and Post-Market Clinical Follow-Up (PMCF) under the MDR: Ensuring safety and performance

What Makes Usability Testing Crucial for Near-Patient and Self-Testing Devices under IVDR?

When does Annex XIV apply in Performance Studies, and what key documentation is needed for compliance?

Get in touch